<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    SIGA Technologies Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About SIGA Technologies Inc.

    SIGA Technologies, Inc. is a public, commercial-stage pharmaceutical company focused on providing solutions for unmet needs in the health security market that comprises medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats, as well as emerging infectious diseases. The company is headquartered in New York City, with research and development facilities in Corvallis, Oregon. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Phillip L Gomez, Ph.D.
    • FOUNDED
      1995
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Cesca Therapeutics Inc.

    Cesca Therapeutics Inc.

    Cesca is a leading regenerative medicine company that develops, commercializes and...

    Cesca is a leading regenerative medicine compan...

    Filing Type:    PU
    Luminex Corporation

    Luminex Corporation

    LuminexÂŽ Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietar...

    LuminexÂŽ Corporation (NASDAQ: LMNX) develops, ...

    Filing Type:    PU
    Allscripts Healthcare Solutions, Inc.

    Allscripts Healthcare Solutions, Inc.

    Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutio...

    Allscripts (NASDAQ: MDRX) is a leader in health...

    Filing Type:    PU
    resTORbio, Inc.

    resTORbio, Inc.

    resTORbio, Inc. is a clinical-stage biopharmaceutical company developing innovativ...

    resTORbio, Inc. is a clinical-stage biopharmace...

    Filing Type:    PU
    Portola Pharmaceuticals, Inc.

    Portola Pharmaceuticals, Inc.

    Portola Pharmaceuticals is a global, commercial-stage biopharmaceutical company fo...

    Portola Pharmaceuticals is a global, commercial...

    Filing Type:    PU
    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc. is an innovative biopharmaceutical company committ...

    Proteostasis Therapeutics, Inc. is an innovativ...

    Filing Type:    PU
    Aethlon Medical, Inc.

    Aethlon Medical, Inc.

    At Aethlon Medical, we are a leading developer of immunotherapeutic technologies t...

    At Aethlon Medical, we are a leading developer ...

    Filing Type:    PU
    Entasis Therapeutics Holdings Inc.

    Entasis Therapeutics Holdings Inc.

    Entasis is a clinical-stage biopharmaceutical company focused on the discovery, de...

    Entasis is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    Chembio Diagnostics, Inc.

    Chembio Diagnostics, Inc.

    Chembio is a leading point-of-care diagnostics company focused on detecting and di...

    Chembio is a leading point-of-care diagnostics ...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.